AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa:... (Publications)
high dose fluconazole for treatment of HIV-associated CM. METHODOLOGY/DESIGN: This is an adaptive open-label phase II/III randomised non-inferiority trial comparing alternative short course AmBisome regimens
Comparison of diagnostic methods for the detection and quantification of the four sympatric <em>Plasmodium</em> species in field samples from Papua... (Publications)
reduced risk of contamination, together with reduced costs per sample through reduced reaction volume, opens the possibility to implement qPCR in endemic settings as a suitable diagnostic tool for large epi
Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine... (Publications)
([(90)Y-DOTA]-TOC) in neuroendocrine cancers. PATIENTS AND METHODS In a clinical phase II single-center open-label trial, patients with neuroendocrine cancers were treated with repeated cycles of [(90)Y-DOTA]-TOC
Potential associations between <em>Schistosoma mansoni</em> infection and physico-chemical characteristics and water-related human activities in Côte... (Publications)
High infection prevalence was observed in villages where children were washing clothes and dishes at open surface water sites and pursued recreational activities (e.g. swimming and playing in the water).
Epidemiological links between malaria parasitaemia and hypertension: findings from a population-based survey in rural Côte d'Ivoire (Publications)
variations are needed to clarify involved biological mechanisms, toward comorbidity management.This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No
Largest Clinical Trial in Africa to Treat COVID-19 Cases is Launched in 13 Countries (News)
https://www.swisstph.ch/en/news/news-detail/news/largest-clinical-trial-in-africa-to-treat-covid-19-cases-is-launched-in-13-countries
training, we aim to support our partners in upholding the highest quality standards." ANTICOV is an open-label, randomised, comparative, ‘adaptive platform trial’ that will test the safety and efficacy of
Closing Symposium of the TIGER Project (News)
https://www.swisstph.ch/en/news/news-detail/news/closing-symposium-of-the-tiger-project
tiger mosquito," said Philipp Hübner, Head of the Cantonal Laboratory of Basel-Stadt during his opening speech at the symposium. “Cross-border cooperation is working well in the fight against the tiger
Achieving Universal Health Coverage in Chad (News)
https://www.swisstph.ch/en/news/news-detail/news/achieving-universal-health-coverage-in-chad
UHC," said Boukari Ouedraogo, coordinator of PADS at Swiss TPH. "Quality and access are the door-openers for engaging communities, finding community champions for health, and putting greater equity into
Outbreak of <em>Cryptosporidium hominis</em> following river flooding in the city of Halle (Saale), Germany, August 2013 (Publications)
consider the potential health risks of long-term surviving parasites persisting on flooded grounds and in open waters even several weeks after the flooding and of bathing places close to sewage spill-overs. Preventive
Simulating the council-specific impact of anti-malaria interventions: a tool to support malaria strategic planning in Tanzania (Publications)
determining appropriate packages of interventions for meeting specific expected targets. METHODS: The OpenMalaria model of malaria dynamics was calibrated for all 184 councils in mainland Tanzania using data
